<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Approach to screening for tuberculosis (TB) infection (latent TB) prior to initiation of a biologic agent or JAK inhibitor</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Approach to screening for tuberculosis (TB) infection (latent TB) prior to initiation of a biologic agent or JAK inhibitor</h1>
<div class="graphic"><div class="figure"><div class="ttl">Approach to screening for tuberculosis (TB) infection (latent TB) prior to initiation of a biologic agent or JAK inhibitor</div><div class="cntnt"><img src="data:png;base64,iVBORw0KGgoAAAANSUhEUgAAAjcAAAGqBAMAAAAFFnidAAAACXBIWXMAAAPoAAAD6AG1e1JrAAAAJFBMVEX///8AAACGhoYpKSm7u7tERETk5OScnJxmZmYRERHMzMxVVVXJmCE6AAAeUUlEQVR42uydz3PbxhXHlyBA8MeFj4ABUr6AhRlX9gWgU0qjE2HlYN9IqrE1zQU0K6WKL6DlxFVPlF1r1JukquJEvVBJ2qmmFzkZT9XJP9f3FqB+kopn2s6Qwb6BZGABLowP3z7sF9i3YkyYMGHChAkTJkyYMGE/YQmYMMtPEpxJ+7YEHAFHwBFwBJxRVok9HAUKuKJYihUWtcJ/5HxFwGFKzxsQnGFR69xvBByll/k9mF340iprAw1egcmkEyZ9bEDRdmuxh9P12RtsVvcOpZOC5KDnqDtvc3ewWdmr/djHHFPa1RDOXQBHVwlOymxtfMdjzlzsPYe1A5t7DmMhHPbvP3wt520Bh+Ao8EClmAM9hNM1GZv15+X8cVHAEZ1AAUfAEXAEHAFn6uC0RhzVbHxofecSzRvq158FHDBCOIl6uKceraCaOBgeXWfX1i5seFLjEhwqH8Lxrp3amxI4SXpqEV1i6/rlS40Pg8OuwLnZc6YMDorwHBQS9XelJCxsQrvevPVbrTRgbXgBC0rFYZvQ9XA13OsWwclBzXMPN8FnVca+99rw1i0ylkZhzzx3IUEV5DtgdUD3Uu5thhUEi4AlPTyVqzH2uBS0lqYEzmrf9luJh/ScoorN6mGtc0dHdSE1jgZvlRod4lnHg/vhXuvNqm77Va++TJ5zX+kdUrNqeD5++g3CGfzIK8j/mN3/gelejrtf2tmT86epQzwVec6eerDkTwcclFLbGHMe9djvoIiX/6gn/TGfJjjrbJEaDMJhXdDCvXi4vglFj20TnI0Xczs85rR9hiKfWo0dVjDHns4hnGSAJ5qFmiHnXTDxVAgnZTCjNRUBmcOxV6vkOV1/PhGEX3w69Jz3HE7gseNBtJfg2D4jOHjdmYPZE09yOBwU+QRnfug5Oi7cc1Km5OxJ+VN6yjhHLrYnHUwHHDDwf9wpYYtpljownw5jTghHwphjUTDpMgmK0V6EkwMT4aQx5uQa7cDL7r4lOCjyEQ7UzmLOt1oUc5qa09WwhJ8qijmx7wRmjfN1yRE95Et3bTi7w7NyqS7gCG0VVzi823spWt6NMZyyzsqB6kj7jOkhHKmBcCpDRbB+Woux5+ipvzRUZ3ZwxXOGcFIQ52alqweGOndIayiYEq4pNZagV+lGymr9faw9R7FaKr/p6iSYLFtqfJadwWYVKau7sfacNmhqv8/hkGBap5hjIpxIWcX5bpXSbbb2yjkKLsJRDe4572MOR4VGlaX/5cjmBThNsCoqjzkx9xzRCRRwBBwBR8CZZjhlaAg4YywLejzgNKPHddQvPntUAYbqalYTTljbOTuyC5Avw2sAiAMc/mpmWZ6JCi88xaE3VVJjOdVn9v55qWKpB9kaHVeOCxzWf1wKyvDNUzBbG8yWYIHgnOL+5ewMq26jwnALsm4SHHk/ghgXOKqxpx6YYbNaC/r81WaiXpXBaZYs2Xjss9zJ8SdhLgCzS1ac4DThK4MZdvEZwZGeOl3QQs9RneWOlQYIWDJQXuZDOCzbjwkcbsv8BSTLvCA4Kc06HvCY07UkB2POWiA56DlHn4RwpK3sfszgPC59tas9a3TNFvuTL0FxeLdaZt4GS83wmBPCkV2w4gRH9JAFHAFHwBFwBJypgnMpt/PK6KKUa930CCM/VF8XS688nm9NoSq32vUhHH41rVGXUhmOu9XDX/plcno0hHYknLP8Y2/q5MOScQ7nhu85Z12Cc+X5Tv4mONPpOaHw/JQGAfpMdgvoORoELQlmNoEG7dnwAAJcDV+dP4fat3AKhqv9AwxdgSeee7gCO+h7tzrQY67WZduKW5RdU6nU3Nu0ZZW1vzdLykfNEtKFgqfuFnJQa1NFJ2VtMAVwvPLDWsdiGYuaFaUJH9Vp4DDBWS2kG7j6qUwvQG2/anOnSVrYrOxVGopMQ0MlGjtKnkM4To6Ogw2llmvwrXsz6V8bTLlDQwNtv+WRrPerLGXaLHsonUwBnBw86kk91vYJDmXCrtPAYYJTYbrUoNUUwdmE4nMt0FOb0EM42+yXHtuWShZL06jjIRwr0QVYsZIB37rryE55Dx1oj7FtjDmy+xus5W9gPtdeAThTIDxTcMFzCM5RnQYOR3Ce0Goq9BwaEmqqRrJnhp6DF5w1zjzH91bnFau7FmCsQc+hrXszuHK0YrEjn/EPsFOs5U3KZNLC4XSo8s0w5uwWIjgYc5ramefQKoeTA7OMIQhjTm8zjDls28Ngw2jUMWMdTSnNK1CQXU2xUu5t2sKY8x0UlTsk9DulqqfAAtbyWKOKyvRR0QkUPWQBR8ARcM5X1YWx8mpUuQz1cZW2Puzc3pUaU3OTC4cnRF2G8Dn+rEBtJJzkSP05FGWVUeXnxp9ER1mg54c+9icWzvp1D1mp4s9qdSSczFjH+QA4Q8+5DIe+ngmF8xpVzw5qIOzhLEI+nHTpnwSmypfvUQzhUlE/3uAv1Te1DmzNyMYiqq+lsAg1FvZooLEEW9ihSTVL7QHLvHTNNE3s9AJmQn/LWe80ysLSo+zQirzbxx4VVkE6YkLhPEW5k51JP0E4e3I+mnSp3eD5UZTBSZLKr1bW/TCkJOqnqcPlXK+v7ixFRaixlHum1CAJhk3HYMmP5o4zwQajiZ0SvNVKJ8uZb2rJO/kfwsHO5DkZa6MdkLupjQmGs81UR67pKuVhhlPnkOe88cMMThRDuMyabPHWgMNxsY/bXgUwWlGRx1WU1KCOND342pNO1++3AZ7RxE6Su0VRv29vpAEo81OPskMrbT/xzN3CKiYYzmvuObmGqVAeJodDMadDnXvK4EQxREu3znK999EQg+SvWJ/HGF7kcf2dIzg21Xj0xZ9ze5kgnNiJsT6qNvb1s79KNQzIlPYZZoei58z6WE2uN8HNap0pFHMGZZ6HyeHQ3Yq/MqcMThRDuFRUs6kN9glOBwxVZ4uk28MigmNtagTnuIj3+iLbUw2SWDSx0yzUjtEH36PYfAcv85T2GWaHUsxZgxpWMcEB+eKt/OY8TB4cxhbleuM+9otLDw2Na/sn+FZ+oRP4E3mYN1pT8z+oBwjXbu6T3AkU8kHAEXAEHAFHwJlUOOLvPsTsGxdwBBwBR8ARcISNsi9YPusLDKOt/dRsCjhjLA00fkLYSMsCzAgK46z5v84S/jlZFwIBYZxlSoLBWJMKgsFYSxmCwXirCwTxMvEk8CY4QsAKOAKOgCPgCDgCjoAj4Ag4Ao6A8/+EczWdXM4LONxWYI7gtC5COoPz30+bPN1wHvjlgX4lp0rACS1rsJzF/6q5qw0o8YWmGNjXSoNFyvMtQ8BmKaVEqcxBMWmtBbGCo+ZZuleQdlp8QgKvvkxTDMi6QtkzJvcc6YHV1Wi2/+7nznoMPUeXjRafkIDS7XGR8+ktAMMurlCzesDbl+rC6v5cHGOO5LRoQoIQDnpOPt2j9KzMl+Q5SxbBSVpd396J4d0KtHoXY04ER4F9hLMItd3/sHc3v20jVwDAHz8kWdJFj2RE2blQy6pFuhdS25VTn0Q7CJI9yVrsJtgTVTnZdXKRojTd9CSnSRB0L7ET2G16kbrYAkYv8iFAgPxznRlKltdfcRpTpqg3EGJYIsTBL49jPnL4Rv+ejTn2PVG9VEbXb1gzhvMxjT8GQzgntDKlD5Q+EA7hEA7hEA7hEA7hEA7hEM7M49DMrhn7HyccwiEcwiEcaoRDOIQzRWfHUTpLligKCYdwCIdwCIdwCIdOKKlRo0aN2sw317/Y/Z/jA0Hn3IsSqK+syXYDe+3I4bS7x+PMPXEm2xHdiR7ON9vH4zSum5PtiLbVTrqaapg6buhJ1NcuHie5sKjqek/HVhOtUrHt/gutNnZLYMOzyfbELBazg91rGmhzlUYVGg8vHkd2SupCdqDJzvvMa7vqVb9M5SCVL0EZvMmOyGYTlVaCkRhyTfpqFSOAoyCu5WTHSDmLcKsEHtTVXAfzJRURJzsimynMDvrXApwbThQix/MTv8kpXYbzPmMMccqpfGnyPTHB5WNOgHNt040Azk+Qeo26z3D4mBPgFPWLwKFGjRo1atSoUaM2w43uWxEO4RAO4RDOaS0a69ZEFCca69ZEFCca69ZEFCca69ZEdUCOxLo1UcWJxLo1UcWJxLo1UcWJxLo1UcWJxLo1kT1DrhJOtNvEcKbx+ayJ4eSm8PsJh3AIh3DijHO45r/3SV/qGbHBOVrz3zsB54QJS0feLscnco7W/P9InCPtdWxwjqn57+rsh9R56pqqawL8jAMdHxmpChaewaLH59pCcnU+4RaSbkF1tVLCveRuy7gkuaaMCzCHFVeT63mvOvU4x9T8Z5FTvS0N0q3H7AVgA2jytpFySsBxxFxbNQ+JQf+/3fVdC0qJWrta3u19Llm21OIHZ3awu/wHiAHOMTX/+WH1Qqo2ENnLh/t6i32+j8NnTAIUtxKW1EFs+wzHYm+2UZeqHdl9znCUVuJBLT5jzq9q/nu+wEm3IN0SV3Ec9rmZcGyw1Z0hDvTvWO37XUhbQ5zdHjAcgB0ROf3lWhwi55ia/01d4Kiuzl4sSLDFPi/qzm6hqQ9xVCwkUEu6uLapBTgyFhjOOlYYTpKNOfHAOUszjnnvTIvXEA6lD5RbEQ7hEE4onRcLYeExCbp0LTezOO0u33FV4DSq+077OHWGU5pBHMQef9B1HDl9OIozq5HDcZILi+xcuF/d4w8nuoWN0Tp8nruk4BLLtoeRI3L0DR329LuorxnmTODITiljgLRcSfwW8yxc5pxgHT6v9x6g3K+ODiueo89VGssVxYLGQ202IkdB/N4B6UY3OJauoBOsw+eB/QMWOvtjDs/R+QOoiH8/wwO6MRmQPT/xexE5TS6SNGUnWIfPg6tt/+o4ckSOXmPbsdhqzArOT5B6ycac6+4rIbKqD9fh87DSxKvjMYeNQxyHjU0Pz/CALp0EEg7hEA7hEA7hXETnj7vjKVVP+TDmOJKTfHUUpz7+McaRa7OWeEpmSj8RB2Yd5xvla8Vaf+RebqI1SsU1NIt6z7xaZ78xHNXV+D3PBr6oKQ8Nc+XDk/3jgnOlY6ecTrYG7zOvx6l45o08uMwDqMxw0pa4ISzX5hiOBjupl7OC86NmJ18vKi1YhFvjVDyF6BhQ/4Hfz4SGfwAnl0TMzwCO2OVft22wX4rIMcapeOYNv6VXZ78FkcPvlsuO7NxkOefO7Py1aoENDSsZjDmjVLxtFrHLcNhvfMzZ1Pjd8szmc/ePDGcFnVk6z7np00ngiZ0v0xkypQ+EQziEEyGcozOVDtX8ZRus1mYKR1pI5cY4By5LsDTzMI6X2h6moVLVO7CdaKWDk7njkj58cRDnA5Gzn5fvp+oHceKYeP4uxxIndlZsZLHisTNlgA1sreBntRXM8WntPX6PnBeONlhe3q7uzbNUfQNFdWt9vgcNfO4WUpsaFkpicjtWY4TzQOM4LJ8ybL/sZUUczDlbLCK2ROQoFr9Hfm0hOzC84JanSNU9Xt3aSHTZdtnu+i8WP6wSNe++I8UJ55HLcVgmbmxgwVP4pZorWMmD/G2e4Yj57bwOMS8czXFudEGk6p6obj3HcRTEh+53HMdqNFtxwQkSz3aOpdxB5ICIHH7DXESOzAuLK0McPs89iByeqrc8Ud2a4zjZLvued7bAuT/oxwpHybGUOxhzzGDMWdWdm2zMaesscvj8do7DC0dznOrqPEvV54Ixh+PwXB3v4NJugePcc90Y4ZyxnX2xhb5POCdthxqlD5RbEQ7hEA7hEA7hEA7hEA7hEM4prZibFRz1yGyA0SXzg9eSPbm2f904OfrARSyhfve0MsDTHjlH5j8ehwMHprplcuMtE911C/q9GOMUxRNFvMJLo+r54OpZrPyM7zAP4kq5lnEvew188u2Cmucz3RR8urmTKDlDnB6f0xRfnOBpu7Jk2XNdUQTF9su2iBxeBmawu+wEh9XtbJfPdFNzaevxnUoQOai35J04H1Z2wQ8ulnfU7Tx/YwML/Jkz/pCn1GklHu0tCpybjbt8ppuaa/gSf05NRI6cF9fi4zvmpFviYnm1A18P+GNpts+fOTM5TltcKbf5VLea8qWY6cYj58oYZzvWf60qm7oPYl5bB9pVXiEmi2YRWxtszOFlYDQZTS+z+aSWMsRMNzWnsjHH2j+s4hw5v2qHHhw/U6WTWTkJTO4QDqUPhEM4hEM4hDNNOFSgfooijXAIh3AIh3AIh3AIh3Amt7spOTe+GJypijHCIRzCIZwY40xXIxzCIRzCiSuOfPncK8PYp82Emy6cf7bOG6dpleMSOeXtsoxL5/mV6lalid3HvNT9tONU/lHu956d63duVN8l39TjEDlOUevAyrl+pwcumiuXejHAUbR+7+0547xj/4qH8KcdJ6Wd85jDcJqYX9WnP3LoPIdwCIca4RDOVODQZVLCiT9OsifBfyZHE8bu7kEu44fT20vtP+cniBPC7hq3zNVwcGADsTvBoyqE3c3hac8Mf1Lri7UjJ9ZC2F0GcSGk3ibw0iTH4zB2t4q1kHqbQnOSOGHsrv3h1UT+37b5cqJ/ykPYXXo+tN4WrYnihLA7WQuttw1/ojgh7C4Z3rmIOtkz5DB2V6UMeWINI9FyEetK6HnsRyeMEeoK4RAO4RBOBHCKp3XRGC4jOVqVwgsPxzht89Jw16OaXp9cGuREHAVRW8VKUKllVFStDofmctRHOBwmLJz9rvDVU050CXA4TPg4vML57eTW8JJI7oDFsTihRs64KwZ8AGcykRP06A3bZcItKPjUNVVXQ7Mui1JsrAe4dAd30BRLm7Tq0lfuZYlvw14YCg7rShMNL7WpZbHS4DXgBkW9B8nhuilt7NqbFRY5Rfz3F7q/x14YKs4qLoJYkGQtl249Tlv8sOr3nkmWDbDb+9zzecQolia/rEvLDrD3xWZhRI7oylt2WLFwsP0yJE0b+KKnMFo3BVJ5+26Z4ZggV9YfVJTPKiFHDhR9sebGWq6B2OAW9Q6s8IJa0EZdnrfqYmkTNV+Xru8tsvfFZqEcVrwriwxHdb/bwMIvaN7X/4LowGjdlA7mS3Cb4diFP9WUHxFfdMPGuTLCSbdgFDlvBc5ujw1F+XqwtInDB2SbvS82K4aCw7oiljyFd7YPf0uyAFliRxqM1k0pp/Kl5A4fkNMPasqDCouf5iQOq/+1dz6/bRxXHB8ufyxFXvg0qyVlX5ahGcfxZUexqVSnHVsF6htFwUnQEykmauxeSClxYPSychLXSS6SG0ioe6FaoK3Qi9jCgYD8c33vLamflPgjMqnAO6elRA6//O6b4fvsG+6QOTElY1vTzWDOIXMMyGnwmzjn+CA9HFaQpZv7KWmCelPD6h8ShxUspCH7QNI94PLg45wT7JuSl3Ye9rXx0ZbEyGm04Yn6y5szJ0wCQ3NCc0JzQnPeCnNuXzFz5vuUKC7FHN2LfmLgnfqLcdcf0Zxjt9EetNXP1K3OdvLgc2cEc7TkzgIe76Dl0S1V9Wn66/5+p4kkjflPgIrR4I1jmcPtutarlRHMafrdz8UdHb8ScJ4mevDtkSYLGLjo85xsye+qQ5pDKx46nyforL85P3YfxB3Dje8Hx1OeOPxE3BKWqDWGMocXXzzcPnPSBzHnv0eaYrax2TNyEtNiJHOQyo2Pkcd5H9EVWBAJyBXzf4QSgrCSBfiAth9tLMNzyIkklNS0UbEDcyhiLK1ebcg6+HX4H9zJ1MEpqNLwkUNSEtfmRR7Ky7A8+2kGe6ErARuAQrRudDUhriup1d/AwbdcJoHCBHtp5lMr2zEHTxh2UvkMNlH1BqXZ/1Q5zMAzo5lT1ivBsJqLeAjjdJYKHqGxaWtRWJ1OlnfMzYcxm06eld7fu3cniByQbI73SYR+8vSah9XPqR8LqzvDzzkkxXCLKcsoPzSt6I0M9sJXAkiIdo40JbJaaO+umcG3RE0UORXErBvTQeQAPBfUSUVXBd3EPelmCexbF19jvMAcp8bm8K3REcaD/YoRjRGENR5ZxkcAdiURmBNtxNfKnWGVyvK1uxcRT0F2ns2ZFx8Xka7Fe2J4cxDA/+Di50JJNzLYS3AlgLZBFYeaENfRHIHPwbdETWxO0je+yXSGVQLPKXVizL6Lqm+BW8jVARrDR04wUXTN4X1ECcZFgc5TlUBYV8mc8g4qSNiFIHJ27x2aY3XNOaCLMTGbIsdic0bJc3Q1/v619DFz6EpAg7ZBPdKEuK6rbM4Ba8IACSLnmDkp6kSk7B3eOlVM/ckfUEqPbys2B3mc9xFdofV1e7mioHujS7su2Zz74KKQPfyXRfdJ75jD3wyBOXWw6/CT4jlnZHN+EObmhjxmzj3IJnHOyZI5HU2I63XJ5tQ5muuSvkxwzsl0h9VPQlAnGnxUvSRLW3JVQTXMkEN8CM0JzQnNCc0JzRmwneCa4rlPIxDLXDEpval8wNYzBdf9FTE9Wic76GHOxKWcR+WjNz3E6TrfnCshpSeVz6jtiMqB28RkV2UxBza3poNjIvaK3ZaP1XXEXOsHUUnTcogNAnXMUX1kZ+RiQSBdVfJf25itG7/BlBRzaYR8A2aCzhflbMviDdDyspX98D6/vIc5E5bSk8qb3lzE+XrVIhVOAbn7t47g41vx/d2/3zFK0XdcJB9Ehcc2kbFA2H0ZIy5GdqbTRSDtiKgzH21QJfI2YTBC/q5XDDpftOK+RRugUfn7OuHyy56RM2EpPalc0/obhChS4a0jd3+hfs/H+jMnslZOAjxvzxuzjhV/x98g+LoFJZu5GAmIuRh7eXcD/CKVSsvxrxGDaf+zdSqnUueLmaRv0QZoJoBrJRCX7d7mTFZKTyrvKtKrtCtXmvYnO+DjQtxprpSNElNxyrbMv3q0kxnB7kuDuJgUVQNFN+2o/2iOFD1iDEbI3229PqaINkBLvaLRjpCPLz8zIU9cSk8q7yqKz5IiHOhxWKBjuBMHYvA2rCEaA3Z6l8hYiCXpNiVxMSpiLqbTpSTv62bA9QRhMEP+3WOKeAO0PPWCuIwv7/FtNWEpw+Q5+LV3wSoPnPDOtCEXhWSumJRLMyc/6539Y7M6CXMuTUqID6E5l2fOiYJlZfAEdCBw4fE/M6g5v1RKxOt12IunThVpzzUn6hSP9JxUdPiYRrzuIaMzExSP//eELHrwtDqoOSNJOfVuHQo5MU2dAAl6EHUGjJwp7wJF4hLMKQ48rEaSMoo5U94g5nCdE3IIJ8V81YTsMtUuMXOSVC786nBhMv08WatXUVqdvClSVIqs4z/WAfMOAhchlNQaj7m/GuERog/yzgZUE1TIQI7pZ85IUkR7lv+Mb6jVQsRryzqUaANrHDdN+LKIxybkavBMSV5GTftdY6dUpHXwbfpFzhxlXQQnHp2ehzH7gBZMTxtULsTTt9e6jZTDp8v7BJ9Naajh8jmai+zHHfz/rseRox2ul2J/jEe0n/TqDkdO6lqyfH2AyBlFSknw0ml8Q936OXKvFL2RSfuP/lPmyImXuNzJuXXN+Xaq8RQ7oMiJeFSb9fpEDtc5i4LhhGM5YSvKPK0YlQup1gcSc9Ugll/gsxFsRIJKkfxKTOpBrgfDStPiZf4rJ7mIPkFlThRNN+Zafc0ZSUrSF7x0mpBDFCK/A/gmEwVYbwTmOHj8lQI0B90q0jJqbz0wh2uzfczhLaAL4iCYGVjRAV/vMEqILXy6xJEifDaCDfFNpMGvpMgRfNNIKkTiMddNWSuiD5nT4MhJl/ubM5IUjpzXHXM+xMgRMTvtC6YyMgePo0hlLpsz1aAOKKGmyLH6msNbQO/lGE5QH9Wf8RgxWXqELTTQaXdxkwa6eIHPRrBBaMkmgV9p4pyTQ3ChDaQ1LV5mjqmR1jSTchLII5xz+pszkhSxxHMOmwMlnHPgiSopeKyUJ0z40sHJZwXU461nZE5MUeiltnxBRVqnOMC31eDXISeTBA4qRf9SKaE5IT6MxZzEUv8FCm+LOcbp35mZmxOJnIu5aHzmKIAiyGqQYNe6TNBNvBMf/Hl85nSloDmLmasROVrE/UcdL3ZPX0Uz3aeN8UXOoZSrEjmBohZGDq3NzHEdJ4/5QZ5/22kscGVjnObQzzphMfMUnLZcBSpTXfa9t4czB2QDzeG1mVTHoWH1PtLQNKaS782IsZpDUtJlHFYVzH2jjqituYKJbXKRY9i06Dtha67jkDk3iYZM93AaGlvkoJRoA825P/NvgO+X4El7nle4TtCc7Y45XMcJIgdpCHkRpsWYzdkmLsIJOf2shCxea4jCXktMfFixOffBfQA3gzmHI0eMf1illFrMLMlWG77YUmuQNd7YHSTDDDk0JzQnNCc0JzQnNCc05+0yJ7zD5Ni2PA9b2MIWtrCFLWxhC1vYfr3t/63TouebpqJfAAAAAElFTkSuQmCC"/></div><div class="graphic_footnotes"><p>JAK: Janus kinase; TB: tuberculosis; IGRA: interferon-gamma release assay; TST: tuberculin skin test; TNF: tumor necrosis factor; IL: interleukin.</p>
<p>* Biologic agents include TNF inhibitors (infliximab, adalimumab, etanercept, certolizumab pegol, or golimumab) and non-TNF agents (abatacept, tocilizumab, rituximab, anifrolumab, ustekinumab, sarilumab, IL-17 blockers, and IL-23 blockers). Janus kinase (JAK) inhibitors include tofacitinib, baricitinib, upadacitinib, deucravacitinib, and others.</p>
<p>¶ Either IGRA or TST may be used; IGRA is preferable if available, particularly for patients who are unlikely to return to have the TST read and for patients with a history of Bacille Calmette-Guérin (BCG) vaccination administered after 12 months of age. Refer to UpToDate topic on the approach to diagnosis (screening) of tuberculosis infection (latent tuberculosis) in adults for discussion of test result interpretation.</p>
<p>Δ A chest radiograph is considered abnormal if it demonstrates parenchymal abnormalities, particularly opacification of the upper lobe or superior segment of the lower lobe. Isolated findings of granuloma/scarring do not warrant workup for TB disease.</p>
<p>◊ Refer to separate UpToDate content for discussion of approach to treatment of TB infection.</p>
<p>§ The optimal interval between initiation of treatment for TB infection and administration of the immunosuppressive agent is uncertain; data to guide the approach are lacking. Patients can start the immunosuppressive agent at any time after starting treatment for TB infection. If feasible, we prefer to administer the immunosuppressive agent once the patient has completed at least several weeks of antituberculous treatment to verify that the patient is tolerating the antituberculous treatment.</p>
¥ Refer to separate UpToDate content for discussion of approach to treatment of TB disease.</div><div class="graphic_reference">Adapted from: Singh JA, Saag KG, Bridges SL Jr, et al. 2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis. Arthritis Care Res (Hoboken) 2016; 68:1.</div><div id="graphicVersion">Graphic 142006 Version 1.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
